Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy. (CORELIA)
COrtical Superficial Siderosis and REcurrent Lobar Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.
Sponsor: University Hospital, Toulouse
A NA clinical study on Cerebral Amyloid Angiopathy, this trial is completed. The trial is conducted by University Hospital, Toulouse and has accumulated 13 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 8 earlier versions
-
Feb 2023 — Aug 2023 [monthly]
Recruiting NA
-
Apr 2022 — Feb 2023 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2019 — Dec 2020 [monthly]
Recruiting NA
-
Dec 2018 — Sep 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting NA
-
Mar 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .